Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

Help us bring fresh perspectives to the table at the 2025 Summit. Invite a friend to join the conversation about ...

equip and support dairy producers in their continuous efforts to provide the best care possible for their dairy animals, Merck Animal Health introduces the Dairy Care365 Training Series. The series ...

Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the company inked with Austria-based drug delivery technology maker Cyprumed ...

Stocks recently featured in the blog include Merck MRK and AbbVie ABBV. Here are highlights from Tuesday’s Analyst Blog: Merck and AbbVie are leading pharmaceutical companies with strong ...

Cyprumed may receive up to $493 million in milestone payments from Merck for peptide drug delivery tech. Merck’s pipeline includes Phase 3 PCSK9 inhibitor and GLP-1/glucagon receptor agonist.

RAHWAY, N.J., April 14, 2025 /PRNewswire/ -- The Merck Manuals is pleased to announce its collaboration with Microsoft to integrate its esteemed professional medical reference into healthcare ...

Merck booked just under $600 million last year in alliance revenues from the pair, but its attention is now moving to new therapies including sotatercept, a TGF-beta-targeting PAH drug Merck ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.